The table below shows ABVC BIOPHARMA, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
$795.95K
-
-
$389.28K
$117.14K
Cost of revenue
-
-
-
-
$296.00
$190.00
Gross profit
-
$795.95K
-
-
$388.98K
$116.95K
R&D
$33.10K
$29.89K
$33.28K
$28.86K
$37.83K
$40.40K
ABVC annual revenue (10-K history)
ABVC BIOPHARMA, INC. reported annual revenue of $296.00K for fiscal year 2025. That is down 41.9% from $509.59K in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.